BioLineRx (BLRX) Debt Ratio (2023 - 2025)
Historic Debt Ratio for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to 0.25.
- BioLineRx's Debt Ratio fell 5197.17% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 5197.17%. This contributed to the annual value of 0.35 for FY2024, which is 12590.64% up from last year.
- As of Q3 2025, BioLineRx's Debt Ratio stood at 0.25, which was down 5197.17% from 0.26 recorded in Q2 2025.
- In the past 5 years, BioLineRx's Debt Ratio registered a high of 0.53 during Q3 2024, and its lowest value of 0.15 during Q4 2023.
- Over the past 3 years, BioLineRx's median Debt Ratio value was 0.25 (recorded in 2025), while the average stood at 0.28.
- As far as peak fluctuations go, BioLineRx's Debt Ratio surged by 14153.58% in 2024, and later crashed by 5197.17% in 2025.
- Quarter analysis of 3 years shows BioLineRx's Debt Ratio stood at 0.15 in 2023, then soared by 125.91% to 0.35 in 2024, then fell by 26.69% to 0.25 in 2025.
- Its Debt Ratio was 0.25 in Q3 2025, compared to 0.26 in Q2 2025 and 0.28 in Q1 2025.